Publication:
Interferon-? for unresectable progressive and symptomatic plexiform neurofibromas

Simple item page
dc.contributor.authorKebudi, Rejin
dc.contributor.authorÇAKIR, FATMA BETÜL
dc.contributor.authorGörgün, Ömer
dc.contributor.institutionauthorÇAKIR, FATMA BETÜL
dc.date.accessioned2019-10-05T13:37:56Z
dc.date.available2019-10-05T13:37:56Z
dc.date.issued2013-04-01
dc.description.abstractNeurofibromas are the most common manifestations of neurofibromatosis type-1. They occasionally cause pain or progressive loss of function due to nerve compression. Optimal treatment approach is still challenging and the current treatment results are not satisfactory. Four cases of plexiform neurofibromas with various clinical presentations and an addendum to a previously published report on a patient who had relief from pain and/or regression of tumor volume after treatment with interferon-alpha 2a are presented.
dc.identifier10.1016/0306-3623(90)91026-n
dc.identifier.citationKebudi R., ÇAKIR F. B. , Görgün Ö., -Interferon-? for unresectable progressive and symptomatic plexiform neurofibromas-, JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, cilt.35, 2013
dc.identifier.doi10.1097/mph.0b013e318270cd24
dc.identifier.scopus84876129283
dc.identifier.urihttps://hdl.handle.net/20.500.12645/2574
dc.identifier.wosWOS:000316554600005
dc.titleInterferon-? for unresectable progressive and symptomatic plexiform neurofibromas
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameGENERAL PHARMACOLOGY
local.avesis.id3ee01f96-2e11-4695-8d9c-c05c9aa1832e
local.avesis.response2444
local.publication.isinternational1
relation.isAuthorOfPublication4b01ee0e-c087-44d4-9581-4d73032d078e
relation.isAuthorOfPublication.latestForDiscovery4b01ee0e-c087-44d4-9581-4d73032d078e
Files
Collections
Yayınlar - Eserler